サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1193222

家畜用寄生虫駆除剤市場：タイプ別、家畜別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Livestock Parasiticides Market By Type , By Livestock, By End user : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 290 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
家畜用寄生虫駆除剤市場：タイプ別、家畜別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年
出版日: 2022年10月01日
発行: Allied Market Research
ページ情報: 英文 290 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

家畜用寄生虫駆除剤駆除剤の市場規模は2021年に26億740万米ドル、2031年には48億5500万米ドルに達し、2022年から2031年にかけてCAGR6.7%を記録すると予測されています。

家畜用寄生虫駆除剤駆除剤市場は、家畜の真菌や細菌以外の寄生虫を駆除する化学物質を提供することを目的としています。これらの化学物質は一般的に製剤化された不活性成分で、その中に1つまたは2つ以上の有効成分から構成されています。寄生虫駆除剤の多くは、化学構造が似ている有効成分を持ち、それらの間には共通する特徴が多くあります。また、それらは異なる化学クラスやファミリーに分類されます。家畜の寄生虫病の予防と治療のために、家畜用寄生虫駆除剤駆除剤の重要性が認識されています。多くの主要なプレーヤーや世界中の企業は、様々な新しい製剤と食中毒の増加有病率を削除するには、家畜寄生虫市場で製品を打ち出しています。

家畜用寄生虫駆除剤駆除剤市場の成長を促進する主な要因は、世界中で動物の健康管理に対する意識が高まっていることです。また、新興国では食糧生産に必要な家畜の数が増加しているため、アニマルヘルスケア製品の需要が高まっています。また、COVID-19が家畜用寄生虫駆除剤駆除剤市場に与える影響はまちまちであることがわかりました。

動物用医薬品の需要に大きな減少があっています。主に臨床管理用医薬品セグメントにおける畜産事業の需要減少は、世界中で続いている社会的距離のガイドラインが獣医臨床訪問の減少につながったことが原因です。しかし、パンデミック時の家畜の健康に対する懸念の高まりは、最終的に市場の需要増につながりました。

家畜用寄生虫駆除剤駆除剤の世界市場は、動物ヘルスケアへの支出増に加え、動物ヘルスケア産業の基盤が確立している北米が圧倒的なシェアを占めています。一方、アジア太平洋地域は、中国やインドなどの国で豚や養鶏場などの最大の動物の農場のいくつかの存在のために、2022年から2031年に7.7％の速いCAGRで成長すると予想され、これは最終的に地域の市場の大幅な成長で結果をもたらします。ラテンアメリカの市場は、畜産動物の人口増加や動物由来食品の消費量増加により、今後成長すると予想されています。

ベジタリアンフードやダイエットへの嗜好の高まりと、家畜用寄生虫駆除剤駆除剤の制限や長い承認プロセスが、世界の家畜用寄生虫駆除剤駆除剤市場に影響を与える抑制要因の一部となっています。家畜用寄生虫駆除剤市場は、タイプ、家畜、エンドユーザー、地域に区分されます。タイプ別では、外部寄生虫駆除剤、内部寄生虫駆除剤、内部寄生虫駆除剤に細分化されます。家畜の種類では、市場は牛、豚、家禽、羊、山羊に分類されます。エンドユーザー別では、動物病院・クリニックと動物飼育場に分けられます。地域別では、北米（米国、カナダ、メキシコ）、欧州（英国、ドイツ、フランス、イタリア、スペイン、オランダ、スイス、欧州のその他）、アジア太平洋（中国、日本、インド、韓国、オーストラリア、インドネシア、タイ、アジア太平洋のその他）、およびLAMEA（南米）で分析されています。

利害関係者にとっての主なメリット

  • 本レポートでは、2021年から2031年までの家畜寄生虫市場分析の市場セグメント、現在の動向、推定、力学を定量的に分析し、家畜寄生虫市場の優勢な機会を特定します。
  • 市場調査は、主要な促進要因、市場抑制要因、機会に関連する情報とともに提供されます。
  • ポーターのファイブフォース分析は、利害関係者が利益志向のビジネス決定を行い、サプライヤーとバイヤーのネットワークを強化できるように、買い手とサプライヤーの効力を強調します。
  • 家畜用寄生虫駆除剤駆除剤の市場セグメンテーションの詳細な分析により、一般的な市場機会を決定するのに役立ちます。
  • 各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。
  • 市場プレイヤーのポジショニングは、ベンチマーキングを容易にし、市場プレイヤーの現在の位置づけを明確に理解することができます。
  • 当レポートでは、地域および世界の家畜用寄生虫駆除剤の市場動向、主要企業、市場セグメント、用途、市場成長戦略に関する分析を掲載しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19 影響分析

第4章 家畜用寄生虫駆除剤駆除剤市場：タイプ別

  • 概要
    • 市場規模および予測
  • 外部寄生虫駆除剤
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 内部寄生虫駆除剤
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 寄生虫駆除剤
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第5章 家畜用寄生虫駆除剤市場：家畜別

  • 概要
    • 市場規模および予測
  • 牛
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 豚
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 家禽類
    • 主要な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 羊・ヤギ
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第6章 家畜用寄生虫駆除剤市場：エンドユーザー別

  • 概要
    • 市場規模・予測
  • 動物病院・クリニック
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別
  • 動物農場
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第7章 家畜用寄生虫駆除剤市場：地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主な動向と機会
    • 北米市場規模・予測：タイプ別
    • 北米市場規模・予測：家畜別
    • 北米市場規模・予測：エンドユーザー別
    • 北米市場規模・予測：国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主な動向と機会
    • 欧州市場規模・予測：タイプ別
    • 欧州市場規模・予測：家畜別
    • 欧州市場規模・予測：エンドユーザー別
    • 欧州市場規模・予測：国別
      • 英国
      • イタリア
      • ドイツ
      • フランス
      • スペイン
      • オランダ
      • スイス
      • その他欧州
  • アジア太平洋地域
    • 主な動向と機会
    • アジア太平洋地域の市場規模・予測：タイプ別
    • アジア太平洋地域の市場規模・予測：家畜別
    • アジア太平洋地域の市場規模・予測：エンドユーザー別
    • アジア太平洋地域の市場規模・予測：国別
      • 中国
      • 日本
      • インド
      • 韓国
      • オーストラリア
      • インドネシア
      • タイ
      • その他アジア太平洋地域
  • LAMEA
    • 主な動向と機会
    • LAMEAの市場規模・予測：タイプ別
    • LAMEAの市場規模・予測：家畜別
    • LAMEAの市場規模・予測：エンドユーザー別
    • LAMEAの市場規模・予測：国別
      • ラテンアメリカ
      • 中東
      • アフリカ

第8章 企業情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合のヒートマップ
  • 主な発展

第9章 企業プロファイル

  • Elanco Animal Health Incorporated
  • BOEHRINGER INGELHEIM GMBH
  • Zoetis Inc
  • MERCK & CO., INC
  • VIRBAC
  • VETOQUINOL S.A.
  • PETIQ, LLC
  • sequent scientific limited
  • KRKA GROUP
  • ECO ANIMAL HEALTH GROUP PLC
  • CEVA SANTE ANIMALE
  • CHANELLE PHARMA
  • BIMEDA ANIMAL HEALTH
  • NORBROOK
  • KYORITSU SEIYAKU CORPORATION
図表

LIST OF TABLES

  • TABLE 1. GLOBAL LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 2. LIVESTOCK PARASITICIDES MARKET, FOR ECTOPARASITICIDES , BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. LIVESTOCK PARASITICIDES MARKET FOR ECTOPARASITICIDES , BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. LIVESTOCK PARASITICIDES MARKET, FOR ENDOPARASITICIDES , BY REGION, 2021-2031 ($MILLION)
  • TABLE 5. LIVESTOCK PARASITICIDES MARKET FOR ENDOPARASITICIDES , BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. LIVESTOCK PARASITICIDES MARKET, FOR ENDECTOCIDES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. LIVESTOCK PARASITICIDES MARKET FOR ENDECTOCIDES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 8. GLOBAL LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 9. LIVESTOCK PARASITICIDES MARKET, FOR CATTLE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. LIVESTOCK PARASITICIDES MARKET FOR CATTLE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 11. LIVESTOCK PARASITICIDES MARKET, FOR PIGS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. LIVESTOCK PARASITICIDES MARKET FOR PIGS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 13. LIVESTOCK PARASITICIDES MARKET, FOR POULTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. LIVESTOCK PARASITICIDES MARKET FOR POULTRY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 15. LIVESTOCK PARASITICIDES MARKET, FOR SHEEP AND GOATS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. LIVESTOCK PARASITICIDES MARKET FOR SHEEP AND GOATS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 17. GLOBAL LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 18. LIVESTOCK PARASITICIDES MARKET, FOR VETERINARY CLINICS AND HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 19. LIVESTOCK PARASITICIDES MARKET FOR VETERINARY CLINICS AND HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 20. LIVESTOCK PARASITICIDES MARKET, FOR ANIMAL FARMS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 21. LIVESTOCK PARASITICIDES MARKET FOR ANIMAL FARMS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 22. LIVESTOCK PARASITICIDES MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 23. NORTH AMERICA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 24. NORTH AMERICA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 25. NORTH AMERICA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 26. NORTH AMERICA LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 27. U.S. LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 28. U.S. LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 29. U.S. LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 30. CANADA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 31. CANADA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 32. CANADA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 33. MEXICO LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 34. MEXICO LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 35. MEXICO LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 36. EUROPE LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 37. EUROPE LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 38. EUROPE LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 39. EUROPE LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 40. UK LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 41. UK LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 42. UK LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 43. ITALY LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 44. ITALY LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 45. ITALY LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 46. GERMANY LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 47. GERMANY LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 48. GERMANY LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 49. FRANCE LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 50. FRANCE LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 51. FRANCE LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 52. SPAIN LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 53. SPAIN LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 54. SPAIN LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 55. THE NETHERLANDS LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 56. THE NETHERLANDS LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 57. THE NETHERLANDS LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 58. SWITZERLAND LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 59. SWITZERLAND LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 60. SWITZERLAND LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 61. REST OF EUROPE LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 62. REST OF EUROPE LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 63. REST OF EUROPE LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 64. ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 65. ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 66. ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 67. ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 68. CHINA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 69. CHINA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 70. CHINA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 71. JAPAN LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 72. JAPAN LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 73. JAPAN LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 74. INDIA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 75. INDIA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 76. INDIA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 77. SOUTH KOREA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 78. SOUTH KOREA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 79. SOUTH KOREA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 80. AUSTRALIA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 81. AUSTRALIA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 82. AUSTRALIA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 83. INDONESIA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 84. INDONESIA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 85. INDONESIA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 86. THAILAND  LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 87. THAILAND  LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 88. THAILAND  LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 89. REST OF ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 90. REST OF ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 91. REST OF ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 92. LAMEA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 93. LAMEA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 94. LAMEA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 95. LAMEA LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 96. LATIN AMERICA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 97. LATIN AMERICA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 98. LATIN AMERICA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 99. MIDDLE EAST LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 100. MIDDLE EAST LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 101. MIDDLE EAST LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 102. AFRICA LIVESTOCK PARASITICIDES MARKET, BY TYPE , 2021-2031 ($MILLION)
  • TABLE 103. AFRICA LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK, 2021-2031 ($MILLION)
  • TABLE 104. AFRICA LIVESTOCK PARASITICIDES MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 105.ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT
  • TABLE 106.ELANCO ANIMAL HEALTH INCORPORATED: OPERATING SEGMENTS
  • TABLE 107.ELANCO ANIMAL HEALTH INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 108.ELANCO ANIMAL HEALTH INCORPORATED: NET SALES,
  • TABLE 109.ELANCO ANIMAL HEALTH INCORPORATED: KEY STRATERGIES
  • TABLE 110.BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT
  • TABLE 111.BOEHRINGER INGELHEIM GMBH: OPERATING SEGMENTS
  • TABLE 112.BOEHRINGER INGELHEIM GMBH: PRODUCT PORTFOLIO
  • TABLE 113.BOEHRINGER INGELHEIM GMBH: NET SALES,
  • TABLE 114.BOEHRINGER INGELHEIM GMBH: KEY STRATERGIES
  • TABLE 115.ZOETIS INC: COMPANY SNAPSHOT
  • TABLE 116.ZOETIS INC: OPERATING SEGMENTS
  • TABLE 117.ZOETIS INC: PRODUCT PORTFOLIO
  • TABLE 118.ZOETIS INC: NET SALES,
  • TABLE 119.ZOETIS INC: KEY STRATERGIES
  • TABLE 120. MERCK & CO., INC: COMPANY SNAPSHOT
  • TABLE 121. MERCK & CO., INC: OPERATING SEGMENTS
  • TABLE 122. MERCK & CO., INC: PRODUCT PORTFOLIO
  • TABLE 123. MERCK & CO., INC: NET SALES,
  • TABLE 124. MERCK & CO., INC: KEY STRATERGIES
  • TABLE 125.VIRBAC: COMPANY SNAPSHOT
  • TABLE 126.VIRBAC: OPERATING SEGMENTS
  • TABLE 127.VIRBAC: PRODUCT PORTFOLIO
  • TABLE 128.VIRBAC: NET SALES,
  • TABLE 129.VIRBAC: KEY STRATERGIES
  • TABLE 130.VETOQUINOL S.A.: COMPANY SNAPSHOT
  • TABLE 131.VETOQUINOL S.A.: OPERATING SEGMENTS
  • TABLE 132.VETOQUINOL S.A.: PRODUCT PORTFOLIO
  • TABLE 133.VETOQUINOL S.A.: NET SALES,
  • TABLE 134.VETOQUINOL S.A.: KEY STRATERGIES
  • TABLE 135.PETIQ, LLC: COMPANY SNAPSHOT
  • TABLE 136.PETIQ, LLC: OPERATING SEGMENTS
  • TABLE 137.PETIQ, LLC: PRODUCT PORTFOLIO
  • TABLE 138.PETIQ, LLC: NET SALES,
  • TABLE 139.PETIQ, LLC: KEY STRATERGIES
  • TABLE 140.SEQUENT SCIENTIFIC LIMITED: COMPANY SNAPSHOT
  • TABLE 141.SEQUENT SCIENTIFIC LIMITED: OPERATING SEGMENTS
  • TABLE 142.SEQUENT SCIENTIFIC LIMITED: PRODUCT PORTFOLIO
  • TABLE 143.SEQUENT SCIENTIFIC LIMITED: NET SALES,
  • TABLE 144.SEQUENT SCIENTIFIC LIMITED: KEY STRATERGIES
  • TABLE 145.KRKA GROUP: COMPANY SNAPSHOT
  • TABLE 146.KRKA GROUP: OPERATING SEGMENTS
  • TABLE 147.KRKA GROUP: PRODUCT PORTFOLIO
  • TABLE 148.KRKA GROUP: NET SALES,
  • TABLE 149.KRKA GROUP: KEY STRATERGIES
  • TABLE 150.ECO ANIMAL HEALTH GROUP PLC: COMPANY SNAPSHOT
  • TABLE 151.ECO ANIMAL HEALTH GROUP PLC: OPERATING SEGMENTS
  • TABLE 152.ECO ANIMAL HEALTH GROUP PLC: PRODUCT PORTFOLIO
  • TABLE 153.ECO ANIMAL HEALTH GROUP PLC: NET SALES,
  • TABLE 154.ECO ANIMAL HEALTH GROUP PLC: KEY STRATERGIES
  • TABLE 155. CEVA SANTE ANIMALE: COMPANY SNAPSHOT
  • TABLE 156. CEVA SANTE ANIMALE: OPERATING SEGMENTS
  • TABLE 157. CEVA SANTE ANIMALE: PRODUCT PORTFOLIO
  • TABLE 158. CEVA SANTE ANIMALE: NET SALES,
  • TABLE 159. CEVA SANTE ANIMALE: KEY STRATERGIES
  • TABLE 160.CHANELLE PHARMA: COMPANY SNAPSHOT
  • TABLE 161.CHANELLE PHARMA: OPERATING SEGMENTS
  • TABLE 162.CHANELLE PHARMA: PRODUCT PORTFOLIO
  • TABLE 163.CHANELLE PHARMA: NET SALES,
  • TABLE 164.CHANELLE PHARMA: KEY STRATERGIES
  • TABLE 165. BIMEDA ANIMAL HEALTH: COMPANY SNAPSHOT
  • TABLE 166. BIMEDA ANIMAL HEALTH: OPERATING SEGMENTS
  • TABLE 167. BIMEDA ANIMAL HEALTH: PRODUCT PORTFOLIO
  • TABLE 168. BIMEDA ANIMAL HEALTH: NET SALES,
  • TABLE 169. BIMEDA ANIMAL HEALTH: KEY STRATERGIES
  • TABLE 170.NORBROOK: COMPANY SNAPSHOT
  • TABLE 171.NORBROOK: OPERATING SEGMENTS
  • TABLE 172.NORBROOK: PRODUCT PORTFOLIO
  • TABLE 173.NORBROOK: NET SALES,
  • TABLE 174.NORBROOK: KEY STRATERGIES
  • TABLE 175.KYORITSU SEIYAKU CORPORATION: COMPANY SNAPSHOT
  • TABLE 176.KYORITSU SEIYAKU CORPORATION: OPERATING SEGMENTS
  • TABLE 177.KYORITSU SEIYAKU CORPORATION: PRODUCT PORTFOLIO
  • TABLE 178.KYORITSU SEIYAKU CORPORATION: NET SALES,
  • TABLE 179.KYORITSU SEIYAKU CORPORATION: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.LIVESTOCK PARASITICIDES MARKET SEGMENTATION
  • FIGURE 2.LIVESTOCK PARASITICIDES MARKET,2021-2031
  • FIGURE 3.LIVESTOCK PARASITICIDES MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.LIVESTOCK PARASITICIDES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.LIVESTOCK PARASITICIDES MARKET,BY TYPE ,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ECTOPARASITICIDES  LIVESTOCK PARASITICIDES MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ENDOPARASITICIDES  LIVESTOCK PARASITICIDES MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF ENDECTOCIDES LIVESTOCK PARASITICIDES MARKET,2021-2031(%)
  • FIGURE 16.LIVESTOCK PARASITICIDES MARKET,BY LIVESTOCK,2021(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF CATTLE LIVESTOCK PARASITICIDES MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF PIGS LIVESTOCK PARASITICIDES MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF POULTRY LIVESTOCK PARASITICIDES MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF SHEEP AND GOATS LIVESTOCK PARASITICIDES MARKET,2021-2031(%)
  • FIGURE 21.LIVESTOCK PARASITICIDES MARKET,BY END USER,2021(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF VETERINARY CLINICS AND HOSPITALS LIVESTOCK PARASITICIDES MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF ANIMAL FARMS LIVESTOCK PARASITICIDES MARKET,2021-2031(%)
  • FIGURE 24.LIVESTOCK PARASITICIDES MARKET BY REGION,2021
  • FIGURE 25.U.S. LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 26.CANADA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 27.MEXICO LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 28.UK LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 29.ITALY LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 30.GERMANY LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 31.FRANCE LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 32.SPAIN LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 33.THE NETHERLANDS LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 34.SWITZERLAND LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 35.REST OF EUROPE LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 36.CHINA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 37.JAPAN LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 38.INDIA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 39.SOUTH KOREA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 40.AUSTRALIA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 41.INDONESIA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 42.THAILAND  LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 43.REST OF ASIA-PACIFIC LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 44.LATIN AMERICA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 45.MIDDLE EAST LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 46.AFRICA LIVESTOCK PARASITICIDES MARKET,2021-2031($MILLION)
  • FIGURE 47. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 50.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 51.COMPETITIVE DASHBOARD
  • FIGURE 52.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 53.ELANCO ANIMAL HEALTH INCORPORATED.: NET SALES ,($MILLION)
  • FIGURE 54.BOEHRINGER INGELHEIM GMBH.: NET SALES ,($MILLION)
  • FIGURE 55.ZOETIS INC.: NET SALES ,($MILLION)
  • FIGURE 56. MERCK & CO., INC.: NET SALES ,($MILLION)
  • FIGURE 57.VIRBAC.: NET SALES ,($MILLION)
  • FIGURE 58.VETOQUINOL S.A..: NET SALES ,($MILLION)
  • FIGURE 59.PETIQ, LLC.: NET SALES ,($MILLION)
  • FIGURE 60.SEQUENT SCIENTIFIC LIMITED.: NET SALES ,($MILLION)
  • FIGURE 61.KRKA GROUP.: NET SALES ,($MILLION)
  • FIGURE 62.ECO ANIMAL HEALTH GROUP PLC.: NET SALES ,($MILLION)
  • FIGURE 63. CEVA SANTE ANIMALE.: NET SALES ,($MILLION)
  • FIGURE 64.CHANELLE PHARMA.: NET SALES ,($MILLION)
  • FIGURE 65. BIMEDA ANIMAL HEALTH.: NET SALES ,($MILLION)
  • FIGURE 66.NORBROOK.: NET SALES ,($MILLION)
  • FIGURE 67.KYORITSU SEIYAKU CORPORATION.: NET SALES ,($MILLION)
目次
Product Code: A31345

The livestock parasiticides market size was valued at $2,607.4 million in 2021, and is projected to reach $4,855 million by 2031, registering a CAGR of 6.7% from 2022 to 2031. The livestock parasiticides market is meant to provide the chemical substances that remove parasites other than fungi and bacteria in livestock. These chemicals are generally inert ingredients that are made in a formulation and consist of one or more than one active ingredient in it. Most of the parasiticidal have active ingredients, which have similar chemical structures and have many of the common features among them. They are grouped into different chemical classes and families as well. The importance of the livestock parasiticides has been recognized for the protection and the cure of parasitic diseases in the animal. Many key players and the companies throughout the world are coming up with various new formulations and the products in the livestock parasiticides market to remove the increasing prevalence of the foodborne diseases.

The major factors that drive the growth of the livestock parasiticides market are increasing awareness about animal healthcare worldwide. Moreover, the escalating number of livestock animals for the purpose of food production in the emerging economies is leading to rising demand for animal healthcare products. And surge in the animal healthcare expenditure for animal welfare to improve their health of livestock animals further fuels the overall livestock parasiticides market.It was also found that there was mixed impact of COVID-19 on livestock parasiticides market.

There was significant decline in the demand for animal health products. The decline in demand for livestock business primarily in clinical administrator pharmaceuticals segment was due to social distancing guidelines followed across the globe led to decrease in veterinary clinical visit.. However, the rising concern about the livestock health during the pandemic ultimately led to increase in market demand.

The market in North America dominates the global livestock parasiticides market due to its well-established base of animal health industry along with rise in expenditure on animal healthcare. Whereas Asia-Pacific is expected to grow at a faster CAGR of 7.7% from 2022 to 2031, due to the presence of some of the largest animal farms such as pigs and the poultry farms in the countries such as China and India and this ultimately results in the substantial growth of the market in the region. The market in Latin America is expected to grow in upcoming future due to rise in population of livestock animals and increase in consumption of animal derived food products in the region.

A growth in preference for vegetarian food & diet coupled with the restrictions and the long approval process for livestock parasiticides for livestock animals are some of the restraints affecting the global livestock parasiticides market. The livestock parasiticides market is segmented into type, livestock, end user, and region. On the basis of type, the market is fragmented into ectoparasiticides, endoparasiticides , and endectocides. On the basis of livestock, the market is categorized into cattle, pigs, poultry, sheep, and goats. On the basis of end user, the market is bifurcated into veterinary clinics & hospitals and animal farms. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, The Netherlands , Switzerland and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Thailand, and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, & Africa).

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the livestock parasiticides market analysis from 2021 to 2031 to identify the prevailing livestock parasiticides market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the livestock parasiticides market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global livestock parasiticides market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type 

  • Ectoparasiticides 
  • Endoparasiticides 
  • Endectocides

By Livestock

  • Poultry
  • Sheep and goats
  • Cattle
  • Pigs

By End user

  • Veterinary clinics and hospitals
  • Animal farms

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Italy
    • Germany
    • France
    • Spain
    • The Netherlands
    • Switzerland
    • Rest Of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand 
    • Rest Of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa
  • Key Market Players
    • Elanco
    • C.H. Boehringer Sohn AG & Co. KG.
    • Zoetis
    • Merck & Co., Inc.
    • Virbac
    • Vetoquinol
    • PETIQ, LLC
    • SeQuent
    • Krka
    • ECO Animal Health Ltd
    • Ceva
    • Chanelle Pharma
    • Bimeda, Inc.
    • Norbrook
    • Kyoritsuseiyaku

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: LIVESTOCK PARASITICIDES MARKET, BY TYPE 

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Ectoparasiticides 
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Endoparasiticides 
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Endectocides
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country

CHAPTER 5: LIVESTOCK PARASITICIDES MARKET, BY LIVESTOCK

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Cattle
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Pigs
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Poultry
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Sheep and goats
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country

CHAPTER 6: LIVESTOCK PARASITICIDES MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Veterinary clinics and hospitals
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Animal farms
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country

CHAPTER 7: LIVESTOCK PARASITICIDES MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type 
    • 7.2.3 North America Market size and forecast, by Livestock
    • 7.2.4 North America Market size and forecast, by End user
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Type 
      • 7.2.5.1.2 Market size and forecast, by Livestock
      • 7.2.5.1.3 Market size and forecast, by End user
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Type 
      • 7.2.5.2.2 Market size and forecast, by Livestock
      • 7.2.5.2.3 Market size and forecast, by End user
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Type 
      • 7.2.5.3.2 Market size and forecast, by Livestock
      • 7.2.5.3.3 Market size and forecast, by End user
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type 
    • 7.3.3 Europe Market size and forecast, by Livestock
    • 7.3.4 Europe Market size and forecast, by End user
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 UK
      • 7.3.5.1.1 Market size and forecast, by Type 
      • 7.3.5.1.2 Market size and forecast, by Livestock
      • 7.3.5.1.3 Market size and forecast, by End user
      • 7.3.5.2 Italy
      • 7.3.5.2.1 Market size and forecast, by Type 
      • 7.3.5.2.2 Market size and forecast, by Livestock
      • 7.3.5.2.3 Market size and forecast, by End user
      • 7.3.5.3 Germany
      • 7.3.5.3.1 Market size and forecast, by Type 
      • 7.3.5.3.2 Market size and forecast, by Livestock
      • 7.3.5.3.3 Market size and forecast, by End user
      • 7.3.5.4 France
      • 7.3.5.4.1 Market size and forecast, by Type 
      • 7.3.5.4.2 Market size and forecast, by Livestock
      • 7.3.5.4.3 Market size and forecast, by End user
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Type 
      • 7.3.5.5.2 Market size and forecast, by Livestock
      • 7.3.5.5.3 Market size and forecast, by End user
      • 7.3.5.6 The Netherlands
      • 7.3.5.6.1 Market size and forecast, by Type 
      • 7.3.5.6.2 Market size and forecast, by Livestock
      • 7.3.5.6.3 Market size and forecast, by End user
      • 7.3.5.7 Switzerland
      • 7.3.5.7.1 Market size and forecast, by Type 
      • 7.3.5.7.2 Market size and forecast, by Livestock
      • 7.3.5.7.3 Market size and forecast, by End user
      • 7.3.5.8 Rest of Europe
      • 7.3.5.8.1 Market size and forecast, by Type 
      • 7.3.5.8.2 Market size and forecast, by Livestock
      • 7.3.5.8.3 Market size and forecast, by End user
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type 
    • 7.4.3 Asia-Pacific Market size and forecast, by Livestock
    • 7.4.4 Asia-Pacific Market size and forecast, by End user
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 China
      • 7.4.5.1.1 Market size and forecast, by Type 
      • 7.4.5.1.2 Market size and forecast, by Livestock
      • 7.4.5.1.3 Market size and forecast, by End user
      • 7.4.5.2 Japan
      • 7.4.5.2.1 Market size and forecast, by Type 
      • 7.4.5.2.2 Market size and forecast, by Livestock
      • 7.4.5.2.3 Market size and forecast, by End user
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Type 
      • 7.4.5.3.2 Market size and forecast, by Livestock
      • 7.4.5.3.3 Market size and forecast, by End user
      • 7.4.5.4 South Korea
      • 7.4.5.4.1 Market size and forecast, by Type 
      • 7.4.5.4.2 Market size and forecast, by Livestock
      • 7.4.5.4.3 Market size and forecast, by End user
      • 7.4.5.5 Australia
      • 7.4.5.5.1 Market size and forecast, by Type 
      • 7.4.5.5.2 Market size and forecast, by Livestock
      • 7.4.5.5.3 Market size and forecast, by End user
      • 7.4.5.6 Indonesia
      • 7.4.5.6.1 Market size and forecast, by Type 
      • 7.4.5.6.2 Market size and forecast, by Livestock
      • 7.4.5.6.3 Market size and forecast, by End user
      • 7.4.5.7 Thailand 
      • 7.4.5.7.1 Market size and forecast, by Type 
      • 7.4.5.7.2 Market size and forecast, by Livestock
      • 7.4.5.7.3 Market size and forecast, by End user
      • 7.4.5.8 Rest of Asia-Pacific
      • 7.4.5.8.1 Market size and forecast, by Type 
      • 7.4.5.8.2 Market size and forecast, by Livestock
      • 7.4.5.8.3 Market size and forecast, by End user
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type 
    • 7.5.3 LAMEA Market size and forecast, by Livestock
    • 7.5.4 LAMEA Market size and forecast, by End user
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Latin America
      • 7.5.5.1.1 Market size and forecast, by Type 
      • 7.5.5.1.2 Market size and forecast, by Livestock
      • 7.5.5.1.3 Market size and forecast, by End user
      • 7.5.5.2 Middle East
      • 7.5.5.2.1 Market size and forecast, by Type 
      • 7.5.5.2.2 Market size and forecast, by Livestock
      • 7.5.5.2.3 Market size and forecast, by End user
      • 7.5.5.3 Africa
      • 7.5.5.3.1 Market size and forecast, by Type 
      • 7.5.5.3.2 Market size and forecast, by Livestock
      • 7.5.5.3.3 Market size and forecast, by End user

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Elanco Animal Health Incorporated
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 BOEHRINGER INGELHEIM GMBH
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Zoetis Inc
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4  MERCK & CO., INC
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 VIRBAC
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 VETOQUINOL S.A.
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 PETIQ, LLC
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 sequent scientific limited
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 KRKA GROUP
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 ECO ANIMAL HEALTH GROUP PLC
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
  • 9.11  CEVA SANTE ANIMALE
    • 9.11.1 Company overview
    • 9.11.2 Company snapshot
    • 9.11.3 Operating business segments
    • 9.11.4 Product portfolio
    • 9.11.5 Business performance
    • 9.11.6 Key strategic moves and developments
  • 9.12 CHANELLE PHARMA
    • 9.12.1 Company overview
    • 9.12.2 Company snapshot
    • 9.12.3 Operating business segments
    • 9.12.4 Product portfolio
    • 9.12.5 Business performance
    • 9.12.6 Key strategic moves and developments
  • 9.13  BIMEDA ANIMAL HEALTH
    • 9.13.1 Company overview
    • 9.13.2 Company snapshot
    • 9.13.3 Operating business segments
    • 9.13.4 Product portfolio
    • 9.13.5 Business performance
    • 9.13.6 Key strategic moves and developments
  • 9.14 NORBROOK
    • 9.14.1 Company overview
    • 9.14.2 Company snapshot
    • 9.14.3 Operating business segments
    • 9.14.4 Product portfolio
    • 9.14.5 Business performance
    • 9.14.6 Key strategic moves and developments
  • 9.15 KYORITSU SEIYAKU CORPORATION
    • 9.15.1 Company overview
    • 9.15.2 Company snapshot
    • 9.15.3 Operating business segments
    • 9.15.4 Product portfolio
    • 9.15.5 Business performance
    • 9.15.6 Key strategic moves and developments